Form D · Insurance

NEW YORK LIFE INSURANCE CO

New York, NY · CIK 0000071633

Offering snapshot reported Feb 12, 2026 · SEC filing

Reported sold
$850K
Indefinite offering
Investors reported
316
Form D · investor count
Minimum accepted
$1
Reported outside-investor minimum
First sale
Jan 30, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 12, 2026Initial$849,611No comparison316SEC filing
Mar 4, 2025Amendment$2,064,179,530$0vs Mar 13, 20231SEC filing
Feb 12, 2025Initial$863,560No comparison319SEC filing
Feb 22, 2024Amendment$2,064,179,530$0vs Mar 13, 20231SEC filing
Feb 14, 2024Initial$0No comparison314SEC filing
Mar 13, 2023Amendment$2,064,179,530$109,685,145vs Feb 16, 20221SEC filing
Feb 14, 2023Initial$0No comparison313SEC filing
Feb 16, 2022Amendment$1,954,494,385$0vs Feb 9, 20211SEC filing
Jan 31, 2022InitialYet to sellNo comparison311SEC filing
Feb 16, 2021Initial$442,831No comparison214SEC filing
Feb 9, 2021Amendment$1,954,494,385$795,923,715vs Feb 12, 20201SEC filing
Feb 12, 2020Amendment$1,158,570,670$958,570,670vs Feb 13, 20191SEC filing
Jan 28, 2020InitialYet to sellNo comparison0SEC filing
Feb 13, 2019Amendment$200,000,000$0vs Feb 14, 20181SEC filing
Jan 22, 2019InitialYet to sellNo comparison0SEC filing
Dec 10, 2018Initial$22,325,000No comparison1SEC filing
Mar 19, 2018Amendment$51,328,964No comparison2SEC filing
Feb 14, 2018Amendment$200,000,000$0vs Jul 29, 20161SEC filing
Jan 23, 2018InitialYet to sellNo comparison0SEC filing
Mar 17, 2017AmendmentYet to sellNo comparison0SEC filing
Jan 13, 2017InitialYet to sellNo comparison0SEC filing
Jul 29, 2016Initial$200,000,000No comparison1SEC filing
Mar 18, 2016InitialYet to sellNo comparison0SEC filing
Jan 13, 2016InitialYet to sellNo comparison0SEC filing
Jan 14, 2015InitialYet to sellNo comparison0SEC filing
Jan 14, 2014InitialYet to sellNo comparison0SEC filing
Jan 15, 2013InitialYet to sellNo comparison0SEC filing
Jan 13, 2012InitialYet to sellNo comparison0SEC filing
Jan 18, 2011InitialYet to sellNo comparison0SEC filing
Jan 14, 2010InitialYet to sellNo comparison0SEC filing
Jan 21, 2009PaperNot reportedNo comparisonNot reportedSEC filing
Jan 31, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-573469
Interest in Deferred First Year Commission Plan
No commissions or seller renumeration will be paid directly or indirectly in connection with the transaction.

Source: Form D, filed Feb 12, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Betty C. Alewine Director
Erik A. Anderson Executive
Mark E. Arning Executive
Claire L. Babineaux Fontenot Director
Aaron C. Ball Executive
Patricia L. Barbari Executive
Robert M. Baylis Director
Christopher O. Blunt Executive
Frank M. Boccio Executive
Elizabeth K. Brill Executive
Michele G. Buck Director
Robert B. Carter Director
David J. Castellani Executive
Alexander I.M. Cook Executive
David Cruz Executive
John A. Cullen Executive
Shelia K. Davidson Executive
Sheila K. Davidson Executive
Ralph De La Vega Director
Craig L. Desanto Executive
Craig L. De Santo Director, Executive
Mark L. Feidler Director
Eric A. Feldstein Executive
Mark L. Fiedler Director
John T. Fleurant Executive
Kent B. Foster Director
Robert F. Friel Director
Robert M. Gardner Executive
Christina A. Gold Director
Solomon Goldfinger Executive
Howard M. Grosfield Director
Matthew M. Grove Executive
Conrad K. Harper Director
Thomas A. Hendry Executive
Yie Hsin Hung Executive
Alain M. Karaoglan Executive
Christopher D. Kastner Director
John Y. Kim Executive
Donna H. Kinnaird Director
Donna H. Kinnard Director
Natalie Lamarque Executive
Mark J. Madgett Executive
Anthony R. Malloy Executive
Theodore A. Mathas Director
Michael K. Mc Donnell Executive
Amy Miller Executive
Sidney Thomas Moser Director
S. Thomas Moser Director
Richard L. Mucci Executive
George Nichols Iii Executive
Barbara G. Novick Director
Katherine R. O'brien Executive
Paul T. Pasteris Executive
Mark W. Pfaff Executive
Ronald R. Pressman Director
Joseph W. Prueher Director
Joanne H. Rodgers Executive
Carla T. Rutigliano Executive
Thomas C. Schievelbein Director
Thomas C. Schievelben Director
Barry A. Schub Executive
Edward D. Shirley Director
Eileen T. Slevin Executive
Gerald B. Smith Director
Deepa Soni Executive
Michael E. Sproule Executive
Joel M. Steinberg Executive
Paula A. Steiner Director
Frederick O. Terrell Director
Susan A. Thrope Executive
Sonali Virendra Executive
William G. Walter Director
Gary E. Wendlandt Director, Executive
Richard J. Witterschein Executive

Issuer details

Industry: Insurance (See others in industry)

Address:
51 Madison Ave
New York, NY, 10010
Phone: (212) 576-7000